Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
FemPulse gets FDA approval to test a new vaginal device for overactive bladder in women.
FemPulse has received FDA approval to begin a clinical trial for its new device designed to treat overactive bladder in women.
The wearable device, inserted vaginally, aims to provide continuous nerve stimulation as an alternative to medication.
If successful, it could offer a new treatment option for millions of women suffering from OAB.
The company is also seeking regulatory approval in Europe for the device.
3 Articles
FemPulse recibe la aprobación de la FDA para probar un nuevo dispositivo vaginal para la vejiga hiperactiva en las mujeres.